
An Integrative Approach to Treating Patients
Key Takeaways
- Neurobiologic mechanisms were highlighted to explain how psychiatric disorders intersect with somatic symptom amplification and pain processing pathways.
- Evidence supported a causal relationship between physical pain and emotional distress, reinforcing the need to treat both domains concurrently.
LIVE FROM PSYCHIATRIC CONGRESS It is no surprise that pain, depression, and anxiety form a "terrible triad"--but now there’s proof, according to results from research presented1 at the 2010 US Psychiatric and Mental Health Congress.
It is no surprise that pain, depression, and anxiety form a "terrible triad"--but now there’s proof, according to results from research presented1 at the 2010 US Psychiatric and Mental Health Congress (Psych Congress®). In 1 of 4 sessions on Treating the Whole Patient, Charles Raison, MD, spoke about the neurobiology of psychiatric disorders and the mind-body connection. He gave data on the causal effect between physical pain and emotional distress, as well as the importance of having social support to lessen pain (eg, fibromyalgia). Treatment strategies on diagnosing and managing patients from the perspective of wellness were also discussed. Clinicians can improve overall outcomes by focusing on an integrative approach of exercise, meditation, and psychotherapy for patients with comorbid pain, depression, and anxiety.
Dr Raison is associate professor in the department of psychiatry and behavioral sciences and clinical director of the Mind-Body program at Emory University School of Medicine in Atlanta. He is one of a team of Treating the Whole Patient presenters that also included Jon Draud, MS, MD; Rakesh Jain, MD, MPH; and Vladimir Maletic, MD, MS.
References:
References
1. http://www.cmellc.com/psychcongress/syllabus/2010/twp/TWP2.pdf
The articles and interviews featured on this page were developed by Psychiatric Times editorial staff and contributors based on presentations delivered at Psych Congress®, an annual conference produced by HMP Global, LLC. Psychiatric Times is an independent publication and is not affiliated with, endorsed by, or sponsored by HMP Global, LLC. All content on this page reflects the independent editorial judgment of Psychiatric Times and does not represent the views, positions, or communications of HMP Global, LLC.









